A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis

Status:
Recruiting

Trial end date:
2023-03-31

Target enrollment:

Participant gender:

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis.

Phase 2

Shengjing Hospital